“EV Targeting MCF-7 Breast Cancer Cell Lines Inhibit Both MTOR and HIF-1A: Molecular Docking Study”. Medico Legal Update, vol. 21, no. 1, Jan. 2021, pp. 1367-73, https://doi.org/10.37506/mlu.v21i1.2511.